Skip to main content

ARI Leverages a Unique Infrastructure to Provide a Full Continuum of Pharma Services

With locations nationwide, we provide you, our clients, with an unparalleled level of access, expertise, flexibility, and scalability. Our local and regional presence in the hospitals and the communities we serve allows us to offer go-to-market business models and solutions that extend beyond the research lab and into the community, aiding your commercialization process.


What Makes ARI Different?

  • Flexible solutions and staff for accelerated project startup
  • Expedited contract review
  • Scale and flex local and national support as your needs change
  • Central data warehouse
  • Large clinically validated lab service menu for both routine and esoteric testing needs
  • Access to diverse testing platforms
  • Dedicated project managers and clinical research coordinators
  • Access to board-certified medical staff for study design and consultation
  • Ability to assist sponsors in all areas of the development cycle from pre-clinical initiative to regulatory approval, market release, and distribution
  • Access to a diverse national network of ethically collected human biomaterials to accelerate research


Pre-Clinical and Clinical Trial Services

  • Customized and IRB-approved human biomaterials from a national network and specialty physicians
  • Access to board-certified pathologists providing consultation and interpretation services, to support your product development program and companion diagnostic discovery efforts
  • 800+ technical laboratory technicians
  • Dedicated clinical research coordinators across multiple states and healthcare systems
  • Wide variety of available testing platforms
  • Extensive IHC, FISH, and molecular test menus
  • Assay Validation Services
  • Method comparison study capability using multiple platforms
  • Interlaboratory reproducibility study capabilities
  • Specimen and data management
  • Custom specimen kits
  • Project management services
  • Customized digital pathology imaging and annotation services

Post-Trial Support and Product Launch

  • Nationwide lab locations to support the launch of the CDX
  • National salesforce to drive adoption and knowledge of the CDX
  • Dedicated marketing team to support commercial efforts
  • Pathologists can educate local clinicians on new CDX testing through tumor boards and local meetings
  • Data analytic services
Pathology Services

Lab Testing Services:

  • Sanger sequencing
  • Next-generation sequencing
  • PCR-based assays
  • Viral genotyping
  • Immunohistochemistry
  • Image analysis
  • Fluorescence in situ hybridization
  • Flow cytometry
  • Chromosome analysis
  • Data services